Outi Lahdenperä

MD, PhD, Medical director

Outi Lahdenperä joined Herantis' Lymfactin team in 2016 after a long and successful clinical and scientific career at the Cancer clinic of the University of Turku. Lahdenperä received her doctorate in clinical pharmacology and clinical chemistry in 2000. Since 2013, she has been an adjunct professor at the University of Turku. She has more than 20 years experience in clinical drug development and continues her research activities in collaboration with several research groups. Lahdenperä has completed Medimerck Health Care Management and Leadership training in 2015.